Illustrative demo. Every patient, provider and value here is synthetic. No real patient data.
Aidyfor Clinics
Bayview Digestive HealthIBD Program
CTIBD care team

Daniel Reyes

41 · Male · Ulcerative colitis since May 2016

In between treatments · Dr. Anika Patel

Sharing with your practice since Jun 11, through Jun 11, 2027Checked in 30 of last 30 daysUsing Aidy since Jun 1, 2026
Next visit
Tue, Nov 10 · 8:00 AM
Infusion with Infusion Center · in 12 days

Needs a look

Check off as you review
  • Responding to EntyvioFYI
    SCCAI down from 8.8 at the first infusion to 1.1 this week.

Since last visit · Aug 26

  • SCCAI 7.4 → 1.1, moderate to remission.
  • Stools 6 → 3.4 a day.
  • 2 of 2 Entyvio doses logged.
  • Finished Budesonide MMX (Uceris) Oct 9.
  • Fecal calprotectin 230 µg/g (high), Oct 24.
  • Checked in 58 of 64 days.

Getting on Entyvio

Preview
45 days to first dose
Prescribed Aug 15, first dose Sep 29 · Aetna Choice POS II · Infusion Center
  1. PrescribedAug 15 · day 0
    Vedolizumab 300 mg IV induction
  2. Benefits checkAug 17 · day 2
    Medical benefit, prior auth required
  3. Prior auth submittedAug 20 · day 5
  4. ApprovedSep 10 · day 26
    21 days after submission
  5. Copay supportSep 12 · day 28
    EntyvioConnect co-pay program
  6. Infusion scheduledSep 19 · day 35
  7. First doseSep 29 · day 45
    Week 0 infusion
From the patient

Sep 29“First infusion done! Took about 45 minutes.”

Sep 10“Approved!!”

Aug 30“Insurance asked for my colonoscopy report again.”

Averages: 31 days to approval and 45 to first infusion in a published adult IBD clinic study.

Disease course

SCCAIdaily scoreRemissionMildModerateSevere03612Stoolsper day048EntyvioMesalamineBudesonideEventsOct 29Oct 15Oct 1Sep 17Sep 3Aug 20Aug 6
7-day average Daily score Formed Loose (Bristol 6–7) Blood Woke at night Dose taken Late Skipped Daily med logged Steroid Missed Lab Visit Note

Disease activity

Modified SCCAI
1.1
Remission7-day average · ↓7.6 vs a month ago
Days in each band · last 90 days
Remission 7Mild 9Moderate 66
What's driving the score · this week
  • Daytime stools0.4/3
  • Night stools0/2
  • Urgency0.1/3
  • Blood0/3
  • General wellbeing0.6/4

Bowel movements

Daily check-in
3.4/day
7-day average
was 6.7/day Aug 1 – Sep 14
Loose (Bristol 6–7)
0%
Blood in stool
0 of 7 days
Woke at night to go
0 of 7 nights
Urgency
2 /10
Usual stool type · last 90 days
1234567
HardTypicalLoose

Therapy & adherence

Induction
Entyvio vedolizumab
Anti-integrin · Infusion · 300 mg IV · weeks 0, 2, 6, then every 8 weeks
Since Sep 29, 2026 · EntyvioConnect enrolled
Sep 29Oct 13Nov 10

2 of 2 on time
Next due Nov 10 (in 12 days)

Post-dose check after Oct 13: mild headache days 1–2.

  • Mesalamine (Lialda)90%
    4.8 g · once daily · since Sep 20, 2022
  • Budesonide MMX (Uceris)Steroid
    9 mg · once daily · ended Oct 9

Previously: Humira (2019–2025).

Labs

Entered by patient
TestLatestTrendNormalDate
Fecal calprotectin230 µg/g↑ High≤ 50Oct 245 days ago
CRP3.2 mg/L≤ 5Oct 245 days ago
Hemoglobin13.6 g/dL12–16Oct 245 days ago

Symptoms

0–10 · weekly avg
  • Wellbeing (10 = very well)7.6↑4.3
  • Abdominal pain1.3↓2.0
  • Urgency2↓4.3
  • Fatigue3↓3.0
  • Anxiety2.3↓2.2

In their words

Notes
Wants to talk about

“When can I stop the mesalamine? Should we recheck calprotectin after week 6?”

  • Oct 26 3 days ago“Down to 3 BMs a day, barely any blood. Afraid to jinx it.”
  • Oct 14 2 wk ago“Second infusion. Felt wiped out after.”

Food patterns

Meal ↔ symptom analysis
Likely triggers
  • Beer6 meals
Tolerates well
  • Sourdough bread15 meals

Flagged only after 4+ logged exposures.

Scores are Aidy's modified SCCAI (no exam items), computed from each daily check-in. Labs and weights are as the patient entered them. Appointments would come from your schedule.